Instil Bio Stock Forecast, Price & News

Wall Street analysts have given Instil Bio a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Instil Bio wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Instil Bio's stock was trading at $4.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TIL stock has increased by 421.5% and is now trading at $20.86.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Instil Bio include Everest Re Group (RE), American Financial Group (AFG), Alleghany (Y), RenaissanceRe (RNR), Enstar Group (ESGR), Lemonade (LMND), Kemper (KMPR), RLI (RLI), The Hanover Insurance Group (THG), Selective Insurance Group (SIGI), AXIS Capital (AXS), Kinsale Capital Group (KNSL), Mercury General (MCY), White Mountains Insurance Group (WTM) and Palomar (PLMR).
View all of TIL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Instil Bio investors own include Bausch Health Companies (BHC), Saul Centers (BFS), Virtus LifeSci Biotech Products ETF (BBP), BB Healthcare Trust (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), StoneCastle Financial (BANX), Yamana Gold (AUY), A. O. Smith (AOS), Sphere 3D (ANY) and The Andersons (ANDE).

(TIL) raised $250 million in an IPO on Friday, March 19th 2021. The company issued 13,900,000 shares at a price of $17.00-$19.00 per share. Morgan Stanley, Jefferies, Cowen and Truist Securities acted as the underwriters for the IPO.

Instil Bio trades on the NASDAQ under the ticker symbol "TIL."

Instil Bio's quiet period expires on Wednesday, April 28th. Instil Bio had issued 16,000,000 shares in its public offering on March 19th. The total size of the offering was $320,000,000 based on an initial share price of $20.00. During Instil Bio's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of TIL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TIL stock can currently be purchased for approximately $20.86.

Instil Bio has a market capitalization of $2.62 billion.

The official website for Instil Bio is www.tillcap.com.

Instil Bio is headquartered at CONTINENTAL BUILDING 25 CHURCH STREET, HAMILTON D0, HM1Z.

Instil Bio's mailing address is CONTINENTAL BUILDING 25 CHURCH STREET, HAMILTON D0, HM1Z. The company can be reached via email at [email protected]